 Severity of Illness Index
"Severity of Illness Index" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
| Descriptor ID |
D012720
|
| MeSH Number(s) |
E05.318.308.980.438.475.456.500 N05.715.360.300.800.438.375.364.500 N06.850.520.308.980.438.475.364.500
|
| Concept/Terms |
Severity of Illness Index- Severity of Illness Index
- Illness Index Severities
- Illness Index Severity
- Index Severities, Illness
- Index Severity, Illness
|
Below are MeSH descriptors whose meaning is more general than "Severity of Illness Index".
Below are MeSH descriptors whose meaning is more specific than "Severity of Illness Index".
This graph shows the total number of publications written about "Severity of Illness Index" by people in this website by year, and whether "Severity of Illness Index" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 | | 1996 | 0 | 1 | 1 | | 1997 | 1 | 9 | 10 | | 1998 | 0 | 6 | 6 | | 1999 | 1 | 18 | 19 | | 2000 | 0 | 23 | 23 | | 2001 | 2 | 19 | 21 | | 2002 | 3 | 30 | 33 | | 2003 | 2 | 45 | 47 | | 2004 | 1 | 48 | 49 | | 2005 | 3 | 72 | 75 | | 2006 | 4 | 60 | 64 | | 2007 | 7 | 73 | 80 | | 2008 | 4 | 94 | 98 | | 2009 | 11 | 68 | 79 | | 2010 | 9 | 88 | 97 | | 2011 | 12 | 97 | 109 | | 2012 | 10 | 80 | 90 | | 2013 | 17 | 93 | 110 | | 2014 | 11 | 112 | 123 | | 2015 | 4 | 106 | 110 | | 2016 | 14 | 93 | 107 | | 2017 | 16 | 90 | 106 | | 2018 | 10 | 125 | 135 | | 2019 | 17 | 116 | 133 | | 2020 | 9 | 90 | 99 | | 2021 | 15 | 82 | 97 | | 2022 | 1 | 32 | 33 | | 2023 | 1 | 21 | 22 | | 2024 | 18 | 61 | 79 | | 2025 | 2 | 15 | 17 |
To return to the timeline, click here.
Below are the most recent publications written about "Severity of Illness Index" by people in Profiles.
-
Florin TA, Tancredi DJ, Ambroggio L, Babl FE, Dalziel SR, Eckerle M, Mintegi S, Neuman MI, Plint AC, Simon NJ, Kuppermann N. Predicting paediatric pneumonia severity in the emergency department: a multinational prospective cohort study of the Pediatric Emergency Research Network. Lancet Child Adolesc Health. 2025 06; 9(6):383-392.
-
Dean R, Yazdanfar M, Zepeda J, Levy C, Lammert C, Pratt D, Gordon SC, Forman L, Assis DN, McGirr A, McLaughlin M, Mukherjee S, Gungabissoon U, Bowlus CL. Treatment of pruritus in primary sclerosing cholangitis: Analysis of the consortium for autoimmune liver disease registry. Hepatol Commun. 2025 May 01; 9(5).
-
Pathmarajah P, Eid E, Nazaroff J, So J, Mittal V, Harris N, Li S, Lucky AW, Gorell ES, Peoples KG, Pope E, Lara-Corrales I, Paller AS, Wiss K, Perman MJ, Eichenfield LF, Levy ML, Morel KD, Garc?a-Romero MT, McCuaig CC, Saber M, Marinkovich MP, Oro A, Bruckner AL, Tang JY. Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa. Br J Dermatol. 2025 Apr 28; 192(5):917-925.
-
Sayegh R, Tang L, Yun KW, Xu Z, Marzec SA, El-Assal O, Leber AL, Everhart K, Mertz S, Desai A, Cohen DM, Alter SJ, Ambroggio L, Florin TA, Keaton M, Shah SS, Ruddy RM, Wallihan R, Mejias A, Ramilo O. Nasal Mucosal Cytokines as Potential Biomarkers for Assessing Disease Severity and Class of Pathogen in Children With Community-Acquired Pneumonia. J Infect Dis. 2025 Apr 15; 231(4):1031-1040.
-
Dobbin ML, Bernard A, Pyle L, Friedman N, Cree MG, Hawkins SMM, Simon SL. Comparison of WatchPAT to polysomnography measurement of apnea-hypopnea index and obstructive sleep apnea severity in adolescents with overweight and obesity. J Clin Sleep Med. 2025 Apr 01; 21(4):695-702.
-
Verberkmoes S, Mazza GL, Edmondson AC, Scaglia F, Horikoshi S, Kuschel B, Janssen MCH, Mousa J, Larson A, Shah R, McDonald G, Sarafoglou K, Berry G, Kozicz T, Lam C, Morava E. Goal attainment in PMM2-CDG: A new approach measuring meaningful clinical outcomes. Mol Genet Metab. 2025 May; 145(1):109087.
-
Lewis CJ, Johnston JM, Zaragoza Domingo S, Vezina G, D'Souza P, Gahl WA, Adams DA, Tifft CJ, Acosta MT. Retrospective assessment of clinical global impression of severity and change in GM1 gangliosidosis: a tool to score natural history data in rare disease cohorts. Orphanet J Rare Dis. 2025 Mar 14; 20(1):125.
-
Silverberg JI, Anderson P, Cappelleri JC, Piercy J, Levenberg ME, Myers DE, Gerber RA. Burden of mild and moderate atopic dermatitis in adults: results from a real-world study in the United States. Arch Dermatol Res. 2025 Mar 12; 317(1):556.
-
Alexis A, McMichael A, Vashi N, Bhutani T, Rodriguez AO, Yeung J, Choi O, Chan D, Alkousakis T, Bronner DN, Park-Wyllie L, Gao LL, Grimes P, Shahriari M, Yadav G, Kindred C, Taylor SC, Desai SR. Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality Improvement. JAMA Dermatol. 2025 Mar 01; 161(3):256-264.
-
Eichenfield LF, Serrao R, Prajapati VH, Browning JC, Swanson L, Funk T, Gonzalez ME, Hebert AA, Lee M, Boguniewicz M, Simpson EL, Seal MS, Krupa D, Hanna D, Snyder S, Burnett P, Chu DH, Almaraz E, Higham RC, Berk DR. Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5?Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled Trial. Pediatr Dermatol. 2025 Mar-Apr; 42(2):296-304.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|